Isthmus Partners’s Pfizer PFE Stock Holding History

Isthmus Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,160	Closed	-$163K	–	236
2021 Q2	$163K	Buy	+4,160	New	+$162K	0.03%	153
2018 Q4	–	Sell	-1,634	Closed	-$68K	–	245
2018 Q3	$68K	Buy	1,634 +896	+121%	+$34.5K	0.02%	162
2018 Q2	$25K	Hold	738	–	–	0.01%	207
2018 Q1	$25K	Sell	738 -810	-52%	-$27.8K	0.01%	202
2017 Q4	$53K	Hold	1,548	–	–	0.01%	171
2017 Q3	$52K	Hold	1,548	–	–	0.01%	170
2017 Q2	$49K	Hold	1,548	–	–	0.01%	177
2017 Q1	$50K	Hold	1,548	–	–	0.01%	180
2016 Q4	$48K	Hold	1,548	–	–	0.01%	182
2016 Q3	$49K	Buy	1,548 +737	+91%	+$24.6K	0.02%	170
2016 Q2	$27K	Hold	811	–	–	0.01%	191
2016 Q1	$23K	Sell	811 -162	-17%	-$4.63K	0.01%	195
2015 Q4	$30K	Hold	973	–	–	0.01%	202
2015 Q3	$29K	Hold	973	–	–	0.01%	205
2015 Q2	$31K	Hold	973	–	–	0.01%	201
2015 Q1	$32K	Hold	973	–	–	0.01%	195
2014 Q4	$29K	Buy	+973	New	+$27.9K	0.01%	208

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Isthmus Partners's PFE Position: Q3 2021 in Review

Isthmus Partners sold out of Pfizer (PFE) in Q3 2021, closing a stake of 4,160 shares — an estimated $163K sold.

Isthmus Partners first reported a position in PFE in Q4 2014 and held it in 17 quarters. The position peaked at $163K in Q2 2021. 2,806 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

Isthmus Partners reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
Isthmus Partners sold 4,160 Pfizer shares in Q3 2021, an estimated $163K.
Isthmus Partners first reported a position in Pfizer in Q4 2014 and held it in 17 quarters.
Isthmus Partners's Pfizer position peaked at $163K in Q2 2021.
2,806 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Isthmus Partners's 13F filing for Q3 2021, filed 10 Nov 2021.